Rhythm Therapeutics, Inc. Awarded $3.67 million NIH SBIR Fast Track Grant to Develop Gene Therapy for Atrial Fibrillation
Share Article
Chicago-based Rhythm Therapeutics is led by founder Dr. Rishi Arora, Professor of Medicine, Clinical Cardiac Electrophysiology at Northwestern University - The Feinberg School of Medicine; Grant is from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, and from the Small Business Innovation Research program that can total up to $3.67 million; Atrial fibrillation is the most common heart rhythm disorder, affecting six million people in the U.S. and 33 million worldwide.
Rishi Arora, MD, FHRS, FAHA
Share this article
Share this article
TROY, Mich., April 19, 2021 /PRNewswire/ Joya Ganguly, M.D., FACP is being recognized by Continental Who s Who as a Top Electrophysiologist in the field of Medicine in acknowledgment for her unwavering devotion to patient-centered care in her position with Heart & Vascular Institute.
(PRNewsfoto/Continental Who s Who)
At its locations in Dearborn, Detroit, and Southfield, Michigan, Heart & Vascular Institute is proud to deliver the highest standard of cardiovascular care to patients ranging from adolescents to adults of all ages. Their highly trained providers offer state-of-the-art evaluations to identify early heart disease and perform interventional procedures to resolve complex cardiovascular concerns. Pacemakers and implantable cardioverter-defibrillators (ICDs) are available for patients with arrhythmia. Patients receive expert guidance needed to protect their devices and every other step along the way before or after surgery. Heart